NEYPPC Pharmacy - Unlicensed Imported Medicines (wave 2)

Leeds Teaching Hospitals NHS Trust

Value
£43,314,823.84
Published
13 Oct 2026
Deadline
30 Nov 2026
Procedure
Competitive flexible procedure
Category
33600000 — Pharmaceutical products
Location
Leeds, UKE42, LS1 3EX, United Kingdom
Notice reference
096479-2026

Requirements summary

The North East and Yorkshire NHS Pharmaceutical Purchasing Consortium, with Leeds Teaching Hospitals NHS Trust listed as buyer, is establishing a closed framework agreement for unlicensed imported medicines, including products needing over-labelling and translation. The framework supplies NHS and eligible public bodies where licensed alternatives cannot meet patient needs. Estimated value is GBP 36,095,686.53 net (GBP 43,314,823.84 gross), with a contract period from 1 May 2027 to 31 December 2028 and an optional 12-month extension.

Key requirements

  • Suppliers must hold all relevant MHRA licences, authorisations and approvals to import, distribute and supply unlicensed medicines in the UK
  • Suppliers must demonstrate compliance with applicable GMP and GDP standards
  • Framework must supply unlicensed imported medicines, including products requiring over-labelling and translation
  • Medicines must be imported under Regulation 167 of the Human Medicines Regulations 2012 where no suitable licensed alternative exists
  • Evaluation weighting: 60% commercial (price), 30% technical quality, 10% social value and sustainability
  • Contract runs 1 May 2027 to 31 December 2028, with optional 12-month extension to 31 December 2029
NEYPPC Pharmacy - Unlicensed Imported Medicines (wave 2… | ProposAI